Directly acting antivirals are safe and effective in HCV elderly patients: a multicenter real life study
Nicola Pugliese(Humanitas University), Alessio Aghemo, Arianna Dal Buono(Humanitas University), Ana Lleò(Humanitas University), Pier Maria Battezzati(University of Milan), Alessia Giorgini(Università Cattolica del Sacro Cuore), Massimo Zuin(AOL (United States)), Clara Di Benedetto(University of Milan), Paola Zermiani(University of Milan), Rossella Meli(IRCCS Humanitas Research Hospital), Antonio Capogreco(Humanitas University)
Cited by 0
Related Papers
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
|Hepatology|2012|405
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394